Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
|Articles|June 3, 2011
Air Sampler
Oxoid Air Sampler is robust, flexible and easy to use. It will take any 90 or 55mm plates and is designed to monitor microbiological air quality in controlled environments. The Oxoid Air Sampler uses impaction technology that is proven to given reliable and accurate results time after time.
Advertisement
Oxoid Air Sampler is robust, flexible and easy to use. It will take any 90 or 55mm plates and is designed to monitor microbiological air quality in controlled environments. The Oxoid Air Sampler uses impaction technology that is proven to given reliable and accurate results time after time.
The Oxoid Air Sampler is a high specification air sampler designed to monitor microbiological air quality in controlled pharmaceutical, clinical and food processing environments, using proven impaction technology that has been used reliably in quality assurance and infection control applications for many years.
This compact and easily portable system, which can be modified to take 90 or 55m plates, is simple to use, with a straightforward keypad menu to lead the user through a variety of preset or user-defined functions, including:
- flexible sampling volumes
- delayed start feature
- multiple run
- variable interval.
The Oxoid Air Sampler can be operated manually or using an infra-red remote control – ideal for monitoring highly sensitive, closed environments.
For added convenience, it comes with a rechargeable battery, which allows for approximately 5 to 7 hours operation. Air intake of up to 100L/min. ensures efficient sampling and a Pyramid Quality Check system is available for confirming performance on-site. Oxoid Air Samplers can be obtained with heads of aluminium, or stainless steel that can be autoclaved.
Find out more here:
Advertisement
Related to this article
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
CPHI Milan: Packaging and Delivery Decisions Must Reflect Real-World Care
3
Manufacturing Intelligence: Organoids, Organ-on-a-Chip, and the Trust Gap
4
Complying with International Pharmacopoeias
5